Trademark: 88186559
Word
MEZZION
Status Date
Tuesday, May 4, 2021
Registration Number
6337605
Registration Date
Tuesday, May 4, 2021
Filing Date
Thursday, November 8, 2018
Published for Opposition
Tuesday, February 16, 2021
41 Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues
5 Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
44 Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
42 Medical and pharmaceutical research for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorder research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine
The word "MEZZION" with the "O" replaced with an open ended heart with a stylized image of a person therein closing the heart shape.
Color is not claimed as a feature of the mark.
Nov 27, 2018
New Application Office Supplied Data Entered
Nov 12, 2018
New Application Entered
Nov 28, 2018
Notice Of Design Search Code E-Mailed
Jan 22, 2019
Assigned To Examiner
Jan 24, 2019
Non-Final Action Written
Jan 24, 2019
Non-Final Action E-Mailed
Jan 24, 2019
Notification Of Non-Final Action E-Mailed
Jul 24, 2019
Teas Response To Office Action Received
Jul 29, 2019
Assigned To Lie
Jul 31, 2019
Correspondence Received In Law Office
Jul 31, 2019
Teas/Email Correspondence Entered
Aug 2, 2019
Letter Of Suspension E-Mailed
Aug 2, 2019
Notification Of Letter Of Suspension E-Mailed
Aug 2, 2019
Suspension Letter Written
Feb 10, 2020
Suspension Checked - To Attorney For Action
Feb 10, 2020
Suspension Inquiry Written
Feb 10, 2020
Inquiry To Suspension E-Mailed
Feb 10, 2020
Notification Of Inquiry As To Suspension E-Mailed
Jun 25, 2020
Teas Response To Suspension Inquiry Received
Jul 1, 2020
Correspondence Received In Law Office
Jul 1, 2020
Teas/Email Correspondence Entered
Jul 2, 2020
Non-Final Action Written
Jul 2, 2020
Non-Final Action E-Mailed
Jul 2, 2020
Notification Of Non-Final Action E-Mailed
Dec 29, 2020
Teas Response To Office Action Received
Dec 29, 2020
Correspondence Received In Law Office
Dec 30, 2020
Teas/Email Correspondence Entered
Jan 4, 2021
Approved For Pub - Principal Register
Jan 8, 2021
On Hold - Electronic Record Review Required
Jan 14, 2021
Electronic Record Review Complete
Feb 16, 2021
Published For Opposition
Jan 27, 2021
Notification Of Notice Of Publication E-Mailed
Feb 16, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Registered-Principal Register
May 29, 2024
Teas Change Of Domestic Representatives Address
May 29, 2024
Teas Change Of Owner Address Received
May 29, 2024
Teas Change Of Correspondence Received
May 29, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
May 29, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
May 29, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Trademark Alertz updated from USPTO on 2030-01-24
